Sign up
Login
Friday 24th September 2021
13:15 Welcome and introduction (D. Betticher, Fribourg)
Localized Colon Cancer (M. Hübner)
13:20 Complete mesocolic excision and D3 dissection: new standard of care? (D. Christoforidis, Lugano)
13:45 Duration of adjuvant chemotherapy: 3 or 6 months? (U. Güller, Thun)
14:10 Implications of liquid biopsies in resected colorectal cancer patients (T. Kössler, Genève)
14:35 HNPCC: diagnosis and practical implications (C. Weisshaupt, St. Gallen)
15:00 Coffee break
15:30 SIRT in advanced colorectal cancer: how and for whom? (N. Schäfer, Lausanne)
Rectal cancer (C. Weisshaupt)
16:00 Neoadjuvant RT/CRT in locally advanced rectal cancer patients is the standard of care
- Pro (O. Riesterer, Aarau)
- Contra (M. Montemurro, Lausanne)
16:45 Surgical resection: Innovations and standard in 2020 (D. Hahnloser, Lausanne)
17:10 Watch and wait after neoadjuvant chemoradiation
- The Dutch experience (G. Beets, Amsterdam)
- Imaging (G. Beets, Amsterdam)
18:00 Interactive case presentations (U. Güller / M. Hübner)
18:30 Adjourn
Saturday 25th September 2021
Advanced Colorectal cancer (U. Güller)
08:00 PRODIGE7, Colopeg, Prophylochip: Has HIPEC died? (M. Hübner, Lausanne)
08:25 What is new in metastatic colorectal cancer? (A. Wicki, Zürich)
08:50 Should we perform NGS panels in all patients with metastatic colorectal cancer? (D. Köberle, Basel)
09:15 Interactive case presentation (U. Güller / M. Hübner)
10:00 Coffee break
Small bowel, appendix (T. Kössler)
10:30 Appendiceal tumors: Entities and treatment modalities (K. Lehmann, Zürich)
10:55 Systemic treatment for small bowel adenocarcinoma: Treat as colon cancer, or differently? (A. Digklia, Lausanne)
11:20 Treatment options in advanced neuroendocrine tumors of the small bowel (R. Winterhalder, Luzern)
11:50 Wrap up, feedback, award: best case presentation (U. Güller / M. Hübner)
12:15 End